HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats.

Abstract
Regulatory T (Treg) cells play an important role in the resolution of crescentic glomerulonephritis, where a T helper 1 (Th1)-predominant immune response promotes crescent formation. Therefore, agents that increase Treg cells appear to be ideal for suppressing T-cell-mediated renal pathology. We hypothesized that a superagonistic monoclonal antibody for CD28 (JJ316), which has been known to preferentially expand Treg cells in vivo, could prevent nephrotoxic serum-induced nephritis in Wistar-Kyoto rats, one of the experimental models of crescentic glomerulonephritis. Administration of JJ316 attenuated crescent formation, proteinuria and glomerular accumulation of macrophages and CD8(+) T cells. These changes were accompanied by increased infiltration of Treg cells. Among glomerular macrophages, the CD163(+) subset was significantly increased after treatment, suggesting that Treg cells may modulate the phenotype of macrophages leading to resolution of glomerulonephritis. In an adoptive transfer experiment, two T-cell subsets (CD4(+)CD25(+) and CD4(+)CD25(-) T cells) purified from spleens and lymph nodes of donor rats primed with JJ316 3 d before were inoculated into nephritic recipient rats, which recapitulated the beneficial effects of in vivo administration of JJ316. Furthermore, a single injection of JJ316 administered 3 d after disease induction completely protected nephritic rats from death for 2 months. In conclusion, we demonstrated that treatment with JJ316 has a dramatic therapeutic effect on an experimental crescentic glomerulonephritis, possibly due to expansion and activation of Treg cells.
AuthorsYoshitsugu Takabatake, Xiao-Kang Li, Masayuki Mizui, Kenro Miyasato, Isao Matsui, Noritaka Kawada, Enyu Imai, Thomas Hünig, Shiro Takahara, Takashi Wada, Kengo Furuichi, Hiromi Rakugi, Yoshitaka Isaka
JournalMolecular medicine (Cambridge, Mass.) (Mol Med) Vol. 17 Issue 7-8 Pg. 686-96 ( 2011) ISSN: 1528-3658 [Electronic] England
PMID21487638 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD163 antigen
  • CD28 Antigens
  • Cytokines
  • Interleukin-2 Receptor alpha Subunit
  • JJ 316
  • Receptors, Cell Surface
Topics
  • Adoptive Transfer
  • Animals
  • Antibodies, Monoclonal (immunology, pharmacology)
  • Antigens, CD (immunology, metabolism)
  • Antigens, Differentiation, Myelomonocytic (immunology, metabolism)
  • CD28 Antigens (agonists, immunology)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cytokines (genetics, immunology)
  • Dose-Response Relationship, Drug
  • Flow Cytometry
  • Gene Expression (drug effects)
  • Glomerulonephritis (immunology, metabolism, prevention & control)
  • Humans
  • Interleukin-2 Receptor alpha Subunit (immunology, metabolism)
  • Kidney Glomerulus (drug effects, immunology, pathology)
  • Lymph Nodes (drug effects, immunology, metabolism)
  • Lymphocyte Activation (drug effects, immunology)
  • Macrophages (immunology, metabolism)
  • Proteinuria (immunology, metabolism, prevention & control)
  • Rats
  • Rats, Inbred WKY
  • Receptors, Cell Surface (immunology, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • T-Lymphocytes, Regulatory (immunology, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: